retatrutide approval timeline Will the FDA approve retatrutide? Odds & Predictions Retatrutide Hits 30.3% Weight Loss

Comparing retatrutide to other GLP-1 options for women Retatrutide vs semaglutide and tirzepatide: the outcome gap Understanding where retatrutide fits in the current landscape of weight-loss pharmacology helps you evaluate whether it is the right choice for your situation and what to expect if you are transitioning from another medication

Semaglutide has a half-life of approximately 7 days, meaning it may remain detectable in your system for 56 weeks after your final injection

Shotsy GLP-1 Tracker App The GLP-1 tracker for what actually matters

Diana Girnita, a double board-certified rheumatologist with a PhD in immunology and over 20 years of experience

GLP-1s are usually shots that a person injects into their skin once or a few times a week

While neither drug is officially approved by the FDA for weight loss, they are frequently used off-label for this purpose